Cardio-ankle vascular index (CAVI) measured by a new device: protocol for a validation study

Sergio Rico Martín, Valentina Vassilenko, Jorge M de Nicolás Jiménez, Purificación Rey Sánchez, Andreia Serrano, Mariana Martínez Alvarez, Julián F Calderón García, Juan F Sánchez Muñoz-Torrero, Sergio Rico Martín, Valentina Vassilenko, Jorge M de Nicolás Jiménez, Purificación Rey Sánchez, Andreia Serrano, Mariana Martínez Alvarez, Julián F Calderón García, Juan F Sánchez Muñoz-Torrero

Abstract

Introduction: Cardio-ankle vascular index (CAVI) is a new marker of arterial stiffness (AS) that can assess vascular wall stiffness in the aorta, femoral artery and tibial artery. CAVI is less affected by blood pressure at the time of measurement than the gold standard method (carotid-femoral pulse wave velocity (PWV)). Our group has developed a device called VOPITB (Velocidad Onda de Pulso Índice Tobillo Brazo) that uses the oscillometric method and easily and accurately measures the PWV in the arms and legs separately, allowing new AS indices to be studied. This article describes the research protocol to determine CAVI using VOPITB and to validate the device against a reference device (VaSera VS-1500) and assess its clinical utility.

Methods and analyses: A cross-sectional, descriptive and observational study will be conducted. In all, 120 subjects (a minimum of 40% of subjects from any one gender) will be evaluated. CAVI will be determined from the measurement by VOPITB and VaSera VS-1500. For each subject, the average of the three readings taken with each device will be calculated. The Bland-Altman plot will be used to determine whether any bias exists in the data-that is, a tendency of the size of the difference to vary with the mean. The participants will be divided roughly equally between the following age bands: <30, 30-60 and >60 years.

Ethics and dissemination: The study has been approved by the ethics committee of the Hospital San Pedro de Alcántara, Cáceres, Spain. The participants will be required to sign an informed consent form before inclusion in the study, in accordance with the Declaration of Helsinki and WHO standards for observational studies. The dissemination plan of the research study results will be through presentations in relevant national and international conferences and scientific publications in peer-reviewed journals.

Trial registration number: NCT04303546.

Keywords: epidemiology; ischaemic heart disease; vascular medicine.

Conflict of interest statement

Competing interests: JFSM-T has property rights over the patented VOPITB invention (Oficina Española de Patentes y Marcas; number of concession: P201130872; publication number: 2400134) and is consultant for MSD, Astra, Pfizer and Boehringer Ingelheim.

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

References

    1. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010;55:1318–27. 10.1016/j.jacc.2009.10.061
    1. Cooper LL, Palmisano JN, Benjamin EJ, et al. . Microvascular function contributes to the relation between aortic stiffness and cardiovascular events: the Framingham heart study. Circ Cardiovasc Imaging 2016;9. 10.1161/CIRCIMAGING.116.004979
    1. Kaess BM, Rong J, Larson MG, et al. . Aortic stiffness, blood pressure progression, and incident hypertension. JAMA 2012;308:875–81. 10.1001/2012.jama.10503
    1. Laurent S, Cockcroft J, Van Bortel L, et al. . Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006;27:2588–605. 10.1093/eurheartj/ehl254
    1. Van Bortel LM, Laurent S, Boutouyrie P, et al. . Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 2012;30:445–8. 10.1097/HJH.0b013e32834fa8b0
    1. Frimodt-Møller M, Nielsen AH, Kamper A-L, et al. . Reproducibility of pulse-wave analysis and pulse-wave velocity determination in chronic kidney disease. Nephrol Dial Transplant 2008;23:594–600. 10.1093/ndt/gfm470
    1. Di Iorio BR, Cucciniello E, Alinei P, et al. . Reproducibility of regional pulse-wave velocity in uremic subjects. Hemodial Int 2010;14:441–6. 10.1111/j.1542-4758.2010.00471.x
    1. Sigrist MK, Chiarelli G, Levin A, et al. . Pulse wave velocity measurements are reproducible in multiple trained observers: a short report. Nephron Clin Pract 2010;116:c60–4. 10.1159/000314664
    1. Shirai K, Utino J, Otsuka K, et al. . A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb 2006;13:101–7. 10.5551/jat.13.101
    1. Yamashina A, Tomiyama H, Takeda K, et al. . Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002;25:359–64. 10.1291/hypres.25.359
    1. Kawasaki T, Sasayama S, Yagi S, et al. . Non-Invasive assessment of the age related changes in stiffness of major branches of the human arteries. Cardiovasc Res 1987;21:678–87. 10.1093/cvr/21.9.678
    1. Bramwell JC, Hill A. The velocity of the pulse wave in man. Proc R Soc L B 1922.
    1. Schillaci G, Battista F, D’Abbondanza M, et al. . The impact of the cardio-ankle vascular index on left ventricular structure and function. Eur Hear J 2017;19:B30–4. 10.1093/eurheartj/suw062
    1. Shirai K, Hiruta N, Song M, et al. . Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives. J Atheroscler Thromb 2011;18:924–38. 10.5551/jat.7716
    1. Kubozono T, Miyata M, Ueyama K, et al. . Clinical significance and reproducibility of new arterial distensibility index. Circ J 2007;71:89–94. 10.1253/circj.71.89
    1. Matsushita K, Ding N, Kim ED, et al. . Cardio-ankle vascular index and cardiovascular disease: systematic review and meta-analysis of prospective and cross-sectional studies. J Clin Hypertens 2019;21:16–24. 10.1111/jch.13425
    1. Muñoz-Tsorrero JFS, Tardio-Fernandez M, Valverde-Valverde JM, et al. . Pulse wave velocity in four extremities for assessing cardiovascular risk using a new device. J Clin Hypertens 2014;16:378–84. 10.1111/jch.12304
    1. Rico Martín S, de Nicolás Jiménez JM, Moyano Calvente SL, et al. . [Pulse wave velocity of the leg minus that of the arm measured with a custom device correlates to the coronary calcium quantification]. Rev Clin Esp 2016;216:191–7. 10.1016/j.rceng.2016.01.003
    1. Sánchez Babaicoa C, Rico Martín S, Morales E, et al. . JSM-T. [Pulse wave velocity brachial-ankle with a new device]. Rev Clin Esp 2020.
    1. Wilkinson IB, McEniery CM, Schillaci G, et al. . Artery Society guidelines for validation of non-invasive haemodynamic measurement devices: Part 1, arterial pulse wave velocity. Artery Res 2010.
    1. Gómez-Sánchez M, Patino-Alonso MC, Gómez-Sánchez L, et al. . Reference values of arterial stiffness parameters and their association with cardiovascular risk factors in the Spanish population. The EVA study. Rev Esp Cardiol 2020;73:43–52. 10.1016/j.rec.2019.04.016
    1. World Medical Association Declaration of Helsinki Ethical principles for medical research involving human subjects. JAMA 2013;310:2191–4.
    1. Williams B, Mancia G, Spiering W, et al. . ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of cardiology and the European Society of hypertension: the task force for the management of arterial H. J Hypertens 2018;2018:1953–2041.
    1. Sánchez Muñoz-Torrero JF, Calderón-García JF, De Nicolás-Jiménez JM, et al. . Automatic or manual arterial path for the Ankle-brachial differences pulse wave velocity. PLoS One 2018;13:e0206434. 10.1371/journal.pone.0206434
    1. Butlin M, Qasem A. Large artery stiffness assessment using SphygmoCor technology. Pulse 2017;4:180–92. 10.1159/000452448
    1. Tanaka H, Munakata M, Kawano Y, et al. . Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness. J Hypertens 2009;27:2022–7. 10.1097/HJH.0b013e32832e94e7
    1. Lim J, Pearman M, Park W, et al. . Interrelationships among various measures of central artery stiffness. Am J Hypertens 2016;29:1024–8. 10.1093/ajh/hpw045
    1. Ohkuma T, Ninomiya T, Tomiyama H, et al. . Brachial-Ankle pulse wave velocity and the risk prediction of cardiovascular disease: an individual participant data meta-analysis. Hypertension 2017;69:1045–52. 10.1161/HYPERTENSIONAHA.117.09097

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する